Please login to the form below

Not currently logged in
Email:
Password:

ParagonRx appoints ex-FDA medical officer

Dr Stephen Sun joins consultancy as chief medical officer

Burlington, Massachusetts-based risk-benefit consultancy ParagonRx has appointed Dr Stephen Sun as its new chief medical officer.

Dr Sun was formerly a medical officer at US regulator the FDA and in his new role will provide regulatory and strategy advice on the optimal and safe use of new drugs and devices.

He began his pharmaceutical industry career at Organon, working in drug safety and medical knowledge management, before joining Alpharma as director of drug safety.

He was promoted to senior director of medical affairs and then after King Pharmaceuticals' acquisition of Alpharma, Dr Sun served as King's senior director of pharmacovigilance and risk management.

After gaining OTC experience at Reckitt-Benckiser, Dr Sun Sun joined the FDA as a medical officer, serving in the CDER Division of Risk Management and most recently in the Controlled Substances staff.

In his new role at ParagonRx, part of inVentiv Health, he will report directly to ParagonRx president Jeffrey Fetterman.

“The focus today is on enhanced pharmacovigilance, putting preventions in place before any regulatory body requires it,” Fetterman said. “Dr Sun's FDA experience will enrich the guidance we offer clients to assure that active risk management is at the core of developing all new products and services.”

21st August 2013

From: Regulatory

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Future Market Insights

Future Market Insights is the premier provider of market intelligence and consulting services, serving clients in over 150 countries. FMI...

Latest intelligence

World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...
World Diabetes Day: Interaction and impact of diabetes on mental health
For World Diabetes Day on the 14th November 2018, Nisha Shahrukh - Medical Writer at Mednet Group has written an article depicting the impact diabetes has on mental health. Including...
EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...

Infographics